Daniel, Justin Kirby .
HRN: 22-63-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/01/2024
03/07/2024
IV
585mg
Q6h
Pcap
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes